As of September 2026, according to Bio-Techne's current financial statements, the company's 12-month EPS is $1.17. For the year 2026, the company recorded an earnings per share (EPS) of $1.17, which marks an increase compared to its EPS of $0.47 in 2025. Bio-Techne's earnings per share for the quarterly report ending on Jun 30, 2026 reached $0.35.
The annual EPS for the year 2026 was $1.17, an increase of 148.9% from $0.47 in 2025. For the fiscal quarter that ended on Jun 30, 2026, the per-share earnings was $0.35, showing a 418.2% increase from the same quarter last year. For the twelve months ending June 2026, the EPS is $1.17. For the year 2025, the yearly earnings per share was $0.47, marking a decrease of 56.1% from 2024.
Bio-Techne has registered an increase in EPS of 418.2% during the last 12 months (YoY, quarterly). In the last three years, TECH recorded an average annual EPS growth rate of -13.5%. Bio-Techne had an average annual EPS growth rate of 5.2% during the last 5 years. Across the last decade, TECH had an average annual EPS growth of 5.3%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| QGEN Qiagen NV | 22.02 | 415.8% | 1.8% | 3.9% |
| TMO Thermo Fisher Scientific Inc | 32.75 | 7.2% | 0% | 2% |
| DHR Danaher Corp | 35.42 | -4.9% | -19.7% | 0.4% |
| GE General Electric Company | 37.85 | 35.8% | 447.4% | 12.1% |
| BIO Bio-Rad Laboratories Inc - Class A | 45.88 | 142.6% | N/A | -26.3% |
| BDX Becton Dickinson & Company | 53.57 | -0.9% | -0.6% | 16.2% |
| TECH Bio-Techne Corp | 61.64 | 148.9% | -13.5% | 5.2% |
| STEM Stem Inc | N/A | 115.6% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.